These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20433172)

  • 1. Showdomycin as a versatile chemical tool for the detection of pathogenesis-associated enzymes in bacteria.
    Böttcher T; Sieber SA
    J Am Chem Soc; 2010 May; 132(20):6964-72. PubMed ID: 20433172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds.
    Donald RG; Skwish S; Forsyth RA; Anderson JW; Zhong T; Burns C; Lee S; Meng X; LoCastro L; Jarantow LW; Martin J; Lee SH; Taylor I; Robbins D; Malone C; Wang L; Zamudio CS; Youngman PJ; Phillips JW
    Chem Biol; 2009 Aug; 16(8):826-36. PubMed ID: 19716473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, characterization and expression of escapin, a broadly antimicrobial FAD-containing L-amino acid oxidase from ink of the sea hare Aplysia californica.
    Yang H; Johnson PM; Ko KC; Kamio M; Germann MW; Derby CD; Tai PC
    J Exp Biol; 2005 Sep; 208(Pt 18):3609-22. PubMed ID: 16155232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactam probes as selective chemical-proteomic tools for the identification and functional characterization of resistance associated enzymes in MRSA.
    Staub I; Sieber SA
    J Am Chem Soc; 2009 May; 131(17):6271-6. PubMed ID: 19354235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and structural characterization of capistruin, a lasso peptide predicted from the genome sequence of Burkholderia thailandensis E264.
    Knappe TA; Linne U; Zirah S; Rebuffat S; Xie X; Marahiel MA
    J Am Chem Soc; 2008 Aug; 130(34):11446-54. PubMed ID: 18671394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging bacterial enzyme targets.
    Su Z; Honek JF
    Curr Opin Investig Drugs; 2007 Feb; 8(2):140-9. PubMed ID: 17328230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore identification and virtual screening for methionyl-tRNA synthetase inhibitors.
    Bharatham N; Bharatham K; Lee KW
    J Mol Graph Model; 2007 Mar; 25(6):813-23. PubMed ID: 16996282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein reactivity of natural product-derived γ-butyrolactones.
    Kunzmann MH; Staub I; Böttcher T; Sieber SA
    Biochemistry; 2011 Feb; 50(5):910-6. PubMed ID: 21188974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis (geometry optimization) of nucleosidic antitumor antibiotic showdomycin by Arguslab 4 software.
    Naz A; Bano K; Bano F; Ghafoor NA; Akhtar N
    Pak J Pharm Sci; 2009 Jan; 22(1):78-82. PubMed ID: 19168426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploitation of structural and regulatory diversity in glutamate racemases.
    Lundqvist T; Fisher SL; Kern G; Folmer RH; Xue Y; Newton DT; Keating TA; Alm RA; de Jonge BL
    Nature; 2007 Jun; 447(7146):817-22. PubMed ID: 17568739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinaxanthone, a new FabI inhibitor from Penicillium sp.
    Zheng CJ; Sohn MJ; Kim WG
    J Antimicrob Chemother; 2009 May; 63(5):949-53. PubMed ID: 19282328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New generation of peptide antibiotics.
    Dubin A; Mak P; Dubin G; Rzychon M; Stec-Niemczyk J; Wladyka B; Maziarka K; Chmiel D
    Acta Biochim Pol; 2005; 52(3):633-8. PubMed ID: 16175238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the forgotten transglycosylases.
    Halliday J; McKeveney D; Muldoon C; Rajaratnam P; Meutermans W
    Biochem Pharmacol; 2006 Mar; 71(7):957-67. PubMed ID: 16298347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rugulactone and its analogues exert antibacterial effects through multiple mechanisms including inhibition of thiamine biosynthesis.
    Nodwell MB; Menz H; Kirsch SF; Sieber SA
    Chembiochem; 2012 Jul; 13(10):1439-46. PubMed ID: 22653914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transglutaminase homologue as a condensation catalyst in antibiotic assembly lines.
    Fortin PD; Walsh CT; Magarvey NA
    Nature; 2007 Aug; 448(7155):824-7. PubMed ID: 17653193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of Staphylococcus aureus MurA and MurZ and approaches for detection of peptidoglycan biosynthesis inhibitors.
    Blake KL; O'Neill AJ; Mengin-Lecreulx D; Henderson PJ; Bostock JM; Dunsmore CJ; Simmons KJ; Fishwick CW; Leeds JA; Chopra I
    Mol Microbiol; 2009 Apr; 72(2):335-43. PubMed ID: 19298367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial transglycosylase inhibitors.
    Ostash B; Walker S
    Curr Opin Chem Biol; 2005 Oct; 9(5):459-66. PubMed ID: 16118062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamine effects on antibiotic susceptibility in bacteria.
    Kwon DH; Lu CD
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.